33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.07%
Net income growth above 1.5x BRZE's 3.35%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.70%
Negative yoy D&A while BRZE is 69.60%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
0.23%
SBC growth while BRZE is negative at -5.27%. John Neff would see competitor possibly controlling share issuance more tightly.
-229.04%
Negative yoy working capital usage while BRZE is 67.77%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
79.06%
AR growth well above BRZE's 21.84%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-150.17%
Both reduce yoy inventory, with BRZE at -135.17%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
54.60%
Lower AP growth vs. BRZE's 342.67%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-178.69%
Negative yoy usage while BRZE is 56.09%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
210.38%
Well above BRZE's 1.07%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
54.00%
Operating cash flow growth at 50-75% of BRZE's 88.57%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
-11.68%
Both yoy lines negative, with BRZE at -232.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
8.24%
Purchases well above BRZE's 6.08%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
0.43%
We have some liquidation growth while BRZE is negative at -9.81%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
3906.00%
Growth well above BRZE's 24.13%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
91.39%
Investing outflow well above BRZE's 42.45%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-7.28%
We cut debt repayment yoy while BRZE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-97.96%
Both yoy lines negative, with BRZE at -67.34%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.